Showing results (1241-1250 of 1,412) with videos related to

Sort By:
Pageof 142
NPJ Parkinson'S Disease|July 21, 2017
Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's diseaseSantiago Perez-Lloret, Francisco J Barrantes
NPJ Parkinson'S Disease|July 21, 2017
Analysis of four scales for global severity evaluation in Parkinson's diseasePablo Martínez-Martín, Jose Manuel Rojo-Abuin, Mayela Rodríguez-Violante, et al.
NPJ Parkinson'S Disease|July 21, 2017
Cytoarchitectural changes in the olfactory bulb of Parkinson's disease patientsJohn W Cave, Nana Fujiwara, Ava R Weibman, et al.
NPJ Parkinson'S Disease|July 21, 2017
Effect of levodopa-carbidopa intestinal gel on resting tremors in patients with advanced Parkinson's diseaseHubert H Fernandez, Weining Z Robieson, Krai Chatamra, et al.
NPJ Parkinson'S Disease|July 21, 2017
Cognitive decline in Parkinson's disease: the complex pictureRoberta Biundo, Luca Weis, Angelo Antonini
NPJ Parkinson'S Disease|July 21, 2017
Efficacy and safety of levodopa-carbidopa intestinal gel from a study in Japanese, Taiwanese, and Korean advanced Parkinson's disease patientsMiho Murata, Masahito Mihara, Kazuko Hasegawa, et al.
NPJ Parkinson'S Disease|July 21, 2017
Non-oral dopaminergic therapies for Parkinson's disease: current treatments and the futureK Ray Chaudhuri, Mubasher A Qamar, Thadshani Rajah, et al.
NPJ Parkinson'S Disease|September 12, 2017
Parkinson's disease associated with pure ATXN10 repeat expansionBirgitt Schüle, Karen N McFarland, Kelsey Lee, et al.
NPJ Parkinson'S Disease|January 26, 2018
Erratum: Variable frequency of LRRK2 variants in the Latin American research consortium on the genetics of Parkinson's disease (LARGE-PD), a case of ancestryMario Cornejo-Olivas, Luis Torres, Mario R Velit-Salazar, et al.
NPJ Parkinson'S Disease|December 8, 2017
Targeted kinase inhibition relieves slowness and tremor in a Drosophila model of LRRK2 Parkinson's diseaseAmy C Cording, Nicolas Shiaelis, Stavroula Petridi, et al.
Pageof 142